Veeda Clinical Research appoints Mahesh Bhalgat as group CEO
Ahmedabad-based Veeda Clinical Research, which offers a range of bioequivalence studies and early and late phase clinical trials, has appointed Mahesh Bhalgat as the chief executive officer (CEO). He had held senior leadership roles in Amgen, Sanofi and Biological E.Prior to joining Veeda, Bhalgat was heading operations of Syngene International, a contract research, development and manufacturing organisation, as the chief operating officer.
PE - Investors in Veeda Clinical Research include Sabre Partners and CX Partners.
Want to receive such news items in your inbox? Click Here to sign up for a trial.